Tsinghua University and Imperial College London Forge Groundbreaking Research and Innovation Fund to Catalyze Early-Stage Scientific Discovery
Tsinghua University and Imperial College London have officially launched a significant joint research and innovation fund, signaling a robust commitment to fostering groundbreaking scientific ideas at their nascent stages. This…
Immunocan Secures RMB250 Million Series A Funding to Accelerate Gene-Edited Animal Platforms and AI-Driven Antibody Discovery
Shanghai-based Immunocan, a burgeoning biopharmaceutical company at the forefront of antibody discovery and gene-editing technologies, has successfully closed a RMB250 million (approximately $34.5 million USD) Series A funding round. This…








